The observation that cognitive dysfunction affects multiple sclerosis (MS) patients can be traced back to Charcot, 1 but it would take another hundred years before researchers set about systematically investigating the frequency, nature and correlates of these deficits. Over the past two decades increasing attention has been devoted to this important topic with a publication rate that has grown accordingly from a dozen articles in 1990 to over 200 papers last year. As with all neuropsychiatric disorders, a heightened understanding of impairment has outstripped our knowledge of how best to treat it. This in turn has created a fresh dilemma for clinicians. We now know that 40-60% of all MS patients (the percentage varies according to the study setting) have cognitive dysfunction, but what advice are we to give such a large group of individuals, many of whom are young or in middle age and fearful of prematurely confronting intellectual decline? The question takes on added ecological salience given that cognitive impairment is robustly associated with difficulties relating to work, recreation, relationships and activities of daily living.
All of this makes the article by Motl and colleagues in this edition of Multiple Sclerosis timely and of particular interest. 2 Borrowing from the gerontology literature, they suggest that exercise holds out the promise of cognitive benefits for MS patients. The results of three meta-analyses of randomized controlled trials (RCTs) are summarized and reveal consistent findings, namely that exercise training in older adults with or without dementia leads to cognitive improvement relative to a control condition. Information processing speed, learning, memory and executive function appear to be the domains most beneficially affected, a significant result as these overlap with the areas of cognition more likely to be compromised in MS. [3] [4] [5] Treatment effect sizes in the RCT are moderate. Boosting the construct validity of these data, brain MRI findings from a different series of studies have linked aerobic fitness to less age-related decline in brain gray and white matter density 6 while an analogous finding from a RCT reveals that aerobic exercise resulted in statistically significant increases in gray and white matter volumes, most notably in prefrontal and temporal cortices, those very regions implicated in memory and executive functioning. 7 Motl et al. go on to review a small MS literature that partly replicates these results. Two cross-sectional imaging studies revealed an association between aerobic fitness, better performance on tests of information processing speed and improved brain metrics, both functional and structural. A third study showed that MS patients who were physically more active perceived fewer cognitive difficulties, a result offset by the purely subjective nature of the assessment. On the other hand, a single RCT incorporating objective psychometric inquiry failed to find cognitive benefits in the exercise group, a result dismissed by Motl et al. as more a reflection of poor methodology than a failure of the intervention. In particular, the method of exercise is critiqued for falling short of minimal criteria that must be attained if it is to prove therapeutic.
So where do these findings leave MS patients vis-a`-vis the putative cognitive benefits of controlled exercise? Before attempting an answer, the exercise-cognition literature should be viewed against the backdrop of many and varied cognitive treatments tried thus far. Pharmacologic interventions in cognitively impaired MS subjects have proved disappointing, none more so than with donepezil. It had been hoped that this cholinergic enhancing drug, long the mainstay of the pharmacologic treatment in Alzheimer's disease, would offer comparable benefits in MS. Initial results proved tantalizing. A double-blind placebo-controlled study in 69 MS patients suggested some improvement in memory with the drug, but a subsequent, multi-center trial with a substantially larger sample size failed to replicate the result. 8, 9 Equivocal results also characterize the diseasemodifying data although the possibility of cognitive amelioration with long-term treatment cannot as yet be discounted. Aside from medication, cognitive rehabilitation offers a mixed picture. Compensatory strategies do improve day-to-day function, but patients work around deficits rather than improve them. 10 Cognitive remediation, which in theory is geared towards reversing some of the decline, may not do so. Moreover, it is time consuming, labor intensive and, as such, not widely available. 11 Cognitively impaired MS patients, therefore, have few therapeutic options.
This dearth of readily available effective treatments, as Motl and colleagues note, makes exercise potentially more attractive as a therapeutic option. In this they are correct. Here they could have gone even further, citing benefits to cognition and regional brain volume in other chronic conditions as well, most notably stroke 12 and schizophrenia. 13 'The Time is Ripe!' is their clarion call to action. Researchers are urged to adopt methods and practices from gerontology and apply them to investigating the effects of exercise on cognition in MS. A persuasive point is made, but as clinical trials get under way, researchers would do well to temper their enthusiasm with a cautious realism. Gerontology is not necessarily the best model for MS patients, as the donepezil data have already shown. Growing old may follow a chronic-progressive course, to use a good MS descriptor, but it is not a pathological process and is not associated with the degree of physical disability and perhaps more importantly, the array of brain changes, found in MS. Care will also have to be taken in ensuring exercise does not lead to symptom exacerbation in the MS group. And fatigue will surely be more of an obstacle here. However, none of these challenges are insurmountable as the preliminary MS data reveal and in citing them one cannot lose sight of the many side effects that accompany the pharmacologic agents already tried and found wanting. Exercise is likely to be far more benign in this regard. Perhaps then, the greatest challenge that lies in wait, and here it would be remiss not to make mention of the dementia literature where this issue has surfaced too, is to show that an improvement in information processing speed demonstrated in the neuropsychologist's office, or an increase in hippocampal volume revealed in a threedimensional reconstruction on a computer console, translates into real-world benefits. There is of course only one way to find out and Motl et al. are pointing the way.
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